|
|
|
Insider
Information: |
Deerfield Partners, Lp |
Relationship: |
* Director by Deputiza... |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
26 |
|
Direct
Shares |
650,000 |
|
Indirect Shares
|
48,612,824 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$446,414,172 |
|
|
Total
Shares |
49,262,824 |
|
|
Total
Value |
$446,414,172 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
-2.0
|
0.0
|
Percentage
Gain/Loss : |
-37.9%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Fischer Imaging Corp |
FIMG |
10% Owner |
2005-09-28 |
0 |
2005-09-28 |
0 |
Premium* |
|
Arena Pharmaceuticals Inc |
ARNA |
10% Owner |
2007-10-19 |
0 |
2007-10-19 |
3,238,908 |
Premium* |
|
Vanda Pharmaceuticals Inc. |
VNDA |
Possible Member of 10%... |
2014-12-23 |
0 |
2014-12-23 |
2,793,072 |
Premium* |
|
Ehealth, Inc. |
EHTH |
Possible Member of 10%... |
2015-01-14 |
0 |
2015-01-14 |
1,804,903 |
Premium* |
|
Regenxbio Inc. |
RGNX |
Possible Member of 10%... |
2015-09-22 |
0 |
2015-09-22 |
49,000 |
Premium* |
|
Gyre Therapeutics |
GYRE |
Possible Member of 10%... |
2018-03-06 |
0 |
2018-03-08 |
305,965 |
Premium* |
|
Mallinckrodt plc |
MNK |
*Possible member of 10... |
2018-05-09 |
0 |
2018-05-09 |
8,308,455 |
Premium* |
|
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
*Possible member of 10... |
2018-05-29 |
0 |
2018-05-29 |
843,352 |
Premium* |
|
Aclaris Therapeutics, Inc. |
ACRS |
10% Owner |
2019-05-09 |
0 |
2019-06-27 |
3,159,165 |
Premium* |
|
Korro Bio |
KRRO |
Possible Member of 10%... |
2019-10-07 |
0 |
2019-10-07 |
285,714 |
Premium* |
|
Cabaletta Bio, Inc. |
CABA |
Possible Member of 10%... |
2019-10-29 |
0 |
2019-10-29 |
700,000 |
Premium* |
|
Black Diamond Therapeutics, Inc. |
BDTX |
Possible Member of 10%... |
2020-02-03 |
0 |
2020-02-03 |
778,790 |
Premium* |
|
Schrodinger, Inc. |
SDGR |
Possible Member of 10%... |
2020-02-10 |
0 |
2020-02-10 |
250,000 |
Premium* |
|
Revolution Medicines, Inc. |
RVMD |
Possible Member of 10%... |
2020-02-18 |
0 |
2020-02-18 |
798,795 |
Premium* |
|
Oncology Institute |
TOIIW |
Director by Deputizati... |
2020-03-13 |
0 |
2020-03-13 |
2,500,000 |
Premium* |
|
Generation Bio Co. |
GBIO |
Possible Member of 10%... |
2020-06-16 |
0 |
2020-06-16 |
1,186,215 |
Premium* |
|
Nkarta, Inc. |
NKTX |
Possible Member of 10%... |
2020-07-14 |
0 |
2020-07-14 |
1,209,936 |
Premium* |
|
Caremax Class A |
CMAX |
Director by Deputizati... |
2020-07-21 |
0 |
2021-06-08 |
50,000 |
Premium* |
|
Annexon, Inc. |
ANNX |
Possible Member of 10%... |
2020-07-28 |
0 |
2020-07-28 |
808,914 |
Premium* |
|
Acutus Medical, Inc. |
AFIB |
Director by Deputizati... |
2020-08-05 |
0 |
2021-07-19 |
3,440,811 |
Premium* |
|
Calcimedica Ord Shs |
CALC |
*Possible Member of 10... |
2020-09-29 |
0 |
2020-09-29 |
1,853,967 |
Premium* |
|
Werewolf Therapeutics, Inc. |
HOWL |
Possible Member of 10%... |
2021-05-04 |
0 |
2021-05-04 |
2,552,787 |
Premium* |
|
Nuvalent, Inc. |
NUVL |
Director, 10% Owner |
2022-11-03 |
650,000 |
|
0 |
Premium* |
|
Frazier Lifesciences Acquisition... |
FLAC |
10% Owner |
|
0 |
2022-11-08 |
2,480,199 |
Premium* |
|
Oncorus, Inc. |
ONCR |
Possible Member of 10%... |
2022-12-13 |
0 |
2022-12-30 |
284,697 |
Premium* |
|
Larimar Therapeutics Inc |
LRMR |
* Director by Deputiza... |
2024-02-16 |
0 |
2024-02-16 |
8,929,179 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
66 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
|
2019-06-27 |
4 |
S |
$2.69 |
$1,882,077 |
I/I |
(699,475) |
3,159,165 |
0 |
- |
|
FLAC |
Frazier Lifesciences Acqu... |
10% Owner |
|
2022-11-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,480,199 |
|
- |
|
NUVL |
Nuvalent, Inc. |
Director |
|
2022-11-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
650,000 |
|
- |
|
TOIIW |
Oncology Institute |
Director by Deputization |
|
2020-03-13 |
4 |
A |
$10.00 |
$50,000,000 |
I/I |
5,000,000 |
2,500,000 |
0 |
- |
|
CMAX |
Caremax Class A |
Director by Deputization |
|
2020-07-21 |
4 |
A |
$10.00 |
$33,600,000 |
I/I |
3,360,000 |
3,360,000 |
0 |
- |
|
AFIB |
Acutus Medical, Inc. |
Director by Deputization |
|
2020-08-05 |
4 |
A |
$0.00 |
$0 |
I/I |
2,222 |
2,222 |
0 |
- |
|
AFIB |
Acutus Medical, Inc. |
Director by Deputization |
|
2020-08-10 |
4 |
A |
$0.00 |
$0 |
I/I |
2,841,802 |
2,202,444 |
0 |
- |
|
AFIB |
Acutus Medical, Inc. |
Director by Deputization |
|
2020-08-10 |
4 |
B |
$18.00 |
$27,000,000 |
I/I |
1,500,000 |
2,758,000 |
2.25 |
- |
|
CMAX |
Caremax Class A |
Director by Deputization |
|
2021-06-08 |
4 |
A |
$10.00 |
$100,000,000 |
I/I |
10,000,000 |
400,000 |
0 |
- |
|
CMAX |
Caremax Class A |
Director by Deputization |
|
2021-06-08 |
4 |
OE |
$0.00 |
$0 |
I/I |
3,418,750 |
50,000 |
0 |
- |
|
AFIB |
Acutus Medical, Inc. |
Director by Deputization |
|
2021-07-19 |
4 |
B |
$14.00 |
$14,999,992 |
I/I |
1,071,428 |
3,438,589 |
2.25 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
Possible Member of 10% Group |
|
2014-12-23 |
4 |
B |
$14.23 |
$2,332,713 |
I/I |
162,014 |
1,674,781 |
1.5 |
- |
|
EHTH |
Ehealth, Inc. |
Possible Member of 10% Group |
|
2015-01-14 |
4 |
B |
$19.84 |
$20,302,400 |
I/I |
1,000,000 |
1,804,903 |
1.5 |
- |
|
RGNX |
Regenxbio Inc. |
Possible Member of 10% Group |
|
2015-09-22 |
4 |
B |
$22.00 |
$3,850,000 |
I/I |
175,000 |
49,000 |
1.5 |
- |
|
RGNX |
Regenxbio Inc. |
Possible Member of 10% Group |
|
2015-09-22 |
4 |
A |
$0.00 |
$0 |
I/I |
1,169,042 |
1,169,042 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
Possible Member of 10% Group |
|
2018-03-06 |
4/A |
S |
$29.94 |
$1,619,414 |
I/I |
(52,461) |
311,274 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
Possible Member of 10% Group |
|
2018-03-07 |
4/A |
S |
$30.00 |
$300,000 |
I/I |
(10,000) |
308,526 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
Possible Member of 10% Group |
|
2018-03-08 |
4/A |
S |
$29.03 |
$271,631 |
I/I |
(9,317) |
305,965 |
0 |
- |
|
KRRO |
Korro Bio |
Possible Member of 10% Group |
|
2019-10-07 |
4 |
A |
$0.00 |
$0 |
I/I |
945,720 |
472,860 |
0 |
- |
|
KRRO |
Korro Bio |
Possible Member of 10% Group |
|
2019-10-07 |
4 |
B |
$14.00 |
$3,999,996 |
I/I |
285,714 |
285,714 |
1.5 |
- |
|
CABA |
Cabaletta Bio, Inc. |
Possible Member of 10% Group |
|
2019-10-29 |
4 |
A |
$0.00 |
$0 |
I/I |
928,506 |
464,253 |
0 |
- |
|
CABA |
Cabaletta Bio, Inc. |
Possible Member of 10% Group |
|
2019-10-29 |
4 |
B |
$11.00 |
$7,700,000 |
I/I |
700,000 |
700,000 |
1.5 |
- |
|
BDTX |
Black Diamond Therapeutic... |
Possible Member of 10% Group |
|
2020-02-03 |
4 |
B |
$19.00 |
$7,600,000 |
I/I |
400,000 |
778,790 |
1.5 |
% |
|
BDTX |
Black Diamond Therapeutic... |
Possible Member of 10% Group |
|
2020-02-03 |
4 |
A |
$0.00 |
$0 |
I/I |
378,790 |
378,790 |
0 |
- |
|
SDGR |
Schrodinger, Inc. |
Possible Member of 10% Group |
|
2020-02-10 |
4 |
B |
$17.00 |
$4,250,000 |
I/I |
250,000 |
250,000 |
1.5 |
- |
|
66 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|